Disc Medicine Initiates BEACON, a Phase 2 Clinical Study of Bitopertin in Patients with Erythropoietic Protoporphyria (EPP) and X-linked Protoporphyria (XLP)
10th August 2022
Portfolio
This post references, or is about Disc Medicine. Find out more by clicking below
Print Article
Email Article
Save Article
